Radiogardase®-Cs

Wirkstoff:

Eisen(III)-hexacyanoferrat(II) (unlösl. Berliner Blau)

ATC-Code :

V03AB31

Darreichungsform:

Hartkapsel

Anwendungsgebiete:

Ausscheidung (Dekorporation) bzw. Verhinderung der Aufnahme (Resorption) von Radiocäsium (z.B. Cs-134, Cs-137)

PDF-Download Fachinformation

PDF-Download Gebrauchsinformation

Aus gesetzlichen Gründen dürfen wir Patienten leider nicht über verschreibungspflichtige Medikamente informieren. Wenn Sie den Fachkreisen nach §10 des deutschen Heilmittelwerbegesetzes angehören, finden Sie nach Passwort-Eingabe Informationen zu den verschreibungspflichtigen Medikamenten.

11.05.2016 | Kategorie: » Pharma

Wilson JP et al. 2015; Decorporation of systemically distributed americium by a novel orally administered diethylenetriaminepentaacetic Acid (DTPA) formulation in beagle dogs; Health Phys. 108(3):308-18

Study design: Beagle dogs received various doses of NanoDTPATM capsules to decorporate administered 241Americium (241Am). Efficacy of NanoDTPATM was compared to intravenously … » Mehr

11.05.2016 | Kategorie: » Pharma

Shankar GN et al. 2014; Evaluating the toxicity of novel Zn-DTPA tablet formulation in dogs and rats; Drug Dev. Res. 75(1):37-46

Study design: Beagle dogs were treated with increasing doses of trisodium zinc pentetate (Zn-DTPA) in a novel oral solid tablet form for seven days to determine its toxicity … » Mehr

11.05.2016 | Kategorie: » Vitamine

Schwartz JB et al. 2016; Response of vitamin D concentration to vitamin D₃ administration in older adults without sun exposure: A randomized double-blind trial; J. Am. Geriatr. Soc. 64(1):65-72

Study design: Randomized double-blind investigation to evaluate the 25 OHD levels in elderly nursing home residents after 16 weeks when 800, 2 000 or 4 000 IU/day or 50 000 … » Mehr

11.05.2016 | Kategorie: » Vitamine

Välimäki VV et al. 2016; How well are the optimal serum 25OHD concentrations reached in high-dose intermittent vitamin D therapy? A placebo-controlled study on comparison between 100 000 IU and 200 000 IU of oral D₃ every 3 months in elderly women; Clin. Endocrinol. 84(6):837-44

Study design: Elderly women received 100 000 or 200 000 IU of vitamin D3 or placebo orally every 3 months plus 1 g of calcium daily over one year to test intermittent … » Mehr

Matomo encountered an error: Uncaught TypeError: Argument 1 passed to Twig\Loader\ChainLoader::addLoader() must implement interface Twig\Loader\LoaderInterface, instance of Twig_Loader_Filesystem given, called in /var/customers/webs/heyl/piwik/vendor/twig/twig/src/Loader/ChainLoader.php on line 35 and defined in /var/customers/webs/heyl/piwik/vendor/twig/twig/src/Loader/ChainLoader.php:39 Stack trace: #0 /var/customers/webs/heyl/piwik/vendor/twig/twig/src/Loader/ChainLoader.php(35): Twig\Loader\ChainLoader->addLoader(Object(Twig_Loader_Filesystem)) #1 /var/customers/webs/heyl/piwik/core/Twig.php(153): Twig\Loader\ChainLoader->__construct(Array) #2 /var/customers/webs/heyl/piwik/vendor/php-di/php-di/src/DI/Definition/Resolver/ObjectCreator.php(140): Piwik\Twig->__construct() #3 /var/customers/webs/heyl/piwik/vendor/php-di/php-di/src/DI/Definition/Resolver/ObjectCreator.php(70): DI\Definition\Resolver\ObjectCreator->createInstance(Object(DI\Definition\ObjectDefinition), Array) #4 /var/customers/webs/heyl/piwik/vendor/php-di/php-di/src/DI/D (which lead to: Circular dependency detected while trying to resolve entry 'Piwik\Twig')

HEYL

Chemisch-pharmazeutische Fabrik GmbH & Co. KG

Radiogardase®-Cs

Login für medizinische Fachkreise

Bitte geben Sie hier ihr Heyl-Kennwort ein

Anfrage für Logindaten